In tumour-bearing mice, an increased number of B cells in the spleen is associated with cancer regression and the presence of B220+/CD86+ activated antigen-presenting B cells in the lymphoid organs and in the periphery [20]. The gene discussed is CD86; the disease is neoplasm.